Phase 1 Combined Single and Multiple Rising Dose Study of the Safety and Pharmacokinetics of Metyrapone/Oxazepam Combination (EMB-001)
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Metyrapone/oxazepam (Primary)
- Indications Smoking withdrawal
- Focus Adverse reactions
- Sponsors Embera NeuroTherapeutics
- 21 Jul 2016 Status changed from active, no longer recruiting to completed.
- 19 Jan 2016 Planned End Date changed from 1 Jan 2016 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 19 Jan 2016 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov record.